HighTower Advisors
HSTO

HighTower Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

HighTower Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-51
Closed -$3K – 2569
2020
Q1 		$3K Hold
51
– – ﹤0.01% 2165
2019
Q4 		$4K Hold
51
– – ﹤0.01% 2235
2019
Q3 		$3K Sell
51
-4
-7% -$261 ﹤0.01% 2357
2019
Q2 		$3K Hold
55
– – ﹤0.01% 2342
2019
Q1 		$12K Hold
55
– – ﹤0.01% 2201
2018
Q4 		$19K Hold
55
– – ﹤0.01% 2092
2018
Q3 		$63K Buy
+55
New +$50.7K ﹤0.01% 2106

Other funds holding HSTO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HighTower Advisors's HSTO Position: Q2 2020 in Review

HighTower Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q2 2020, closing a stake of 51 shares — an estimated $3K sold.

HighTower Advisors first reported a position in HSTO in Q3 2018 and held it in 7 quarters. The position peaked at $63K in Q3 2018. 19 funds tracked by Wall St. Rank hold HSTO as of Q2 2020.

  • HighTower Advisors reported no remaining Histogen Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • HighTower Advisors sold 51 Histogen Inc. Common Stock shares in Q2 2020, an estimated $3K.
  • HighTower Advisors first reported a position in Histogen Inc. Common Stock in Q3 2018 and held it in 7 quarters.
  • HighTower Advisors's Histogen Inc. Common Stock position peaked at $63K in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2020.

Based on HighTower Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.